��������

Dr. Yousif Sahly received his doctorate in Organic Chemistry in 1988 from the Technion, Israel Institute of Technology followed by post-doctorate training in Massachusetts Institute of Technology, Cambridge, MA, USA. He has over 25 years of experience in large and emerging pharmaceutical companies in USA and Israel. In the USA he worked at Pfizer as a Director of Drug Metabolism and Pharmacokinetics department and before he worked for Merck as a Senior Scientist in the Department of Drug Metabolism.

He joined Teva in Israel in 2009 where he was a Senior Director, Head of analytical Research and Development. There he managed a department comprised of senior and associate scientists responsible for analytical method development and qualification for drug candidates of small molecules, complex mixtures (such as Copaxone), peptides and oligonucleotides in support of formulation/ chemical development and regulatory submissions. Dr. Sahly has served as the Director of Quality Control at Salzman Group since 2018. He manages both the GMP analytical and GLP bioanalytical laboratories.